Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD). [PDF]
Hwang YM, Kim SJ, Yoo M.
europepmc +1 more source
Hepatitis B Virus, <i>Helicobacter pylori</i> and High-Risk Events of Gastric Cancer Development: An Observational Study (SIGES). [PDF]
Zou JC +6 more
europepmc +1 more source
The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole. [PDF]
Lee KJ, Jung DH, Lee OY.
europepmc +1 more source
Endoscopic spectrum of autoimmune gastritis across disease stages: a focus on Barrett's esophagus and ME-NBI features. [PDF]
Zhang Z +7 more
europepmc +1 more source
Spurious Elevations of Chromogranin A in the Setting of Autoimmune Metaplastic Atrophic Gastritis. [PDF]
Jose E +3 more
europepmc +1 more source
Case Report: Collagenous gastritis presenting with refractory dyspepsia and diffuse gastric atrophic-appearing changes. [PDF]
Sun YN +4 more
europepmc +1 more source
Beyond Type 1 Diabetes: Autoimmune Gastritis-Driven Multisystem Disease in Autoimmune Polyglandular Syndrome Type 3. [PDF]
Ottu Para NK +3 more
europepmc +1 more source
Potassium-competitive Acid Blockers in Gastroesophageal Reflux Disease and Functional Dyspepsia: A Korean Expert Review With Original Meta-analyses. [PDF]
Seo SI +7 more
europepmc +1 more source
Gastroparesis, hypergastrinemia and stomach polypoid lesions in 53-year old patient
A. N. Tazabiyev +8 more
doaj +1 more source
Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist's roadmap for the clinician. [PDF]
Wang CL, Zeng M, Luo Y.
europepmc +1 more source

